Mónica Aróstica

Mrs. Mónica Aróstica


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
DSDaniel E. Sáenz-Martínez
Daniel E. Sáenz-Martínez
PSPaula Santana
Paula Santana
MAMónica Aróstica
Mónica Aróstica
JOJuan Carloa Forero Oliveros
Juan Carloa Forero Oliveros
FGFanny Guzmán
Fanny Guzmán
LMLuis Mercado
Luis Mercado

24 November 2022 in Membranes
Verified
Journal Article
Open access
PDF file
MAMónica Aróstica
Mónica Aróstica
RRRoberto Rojas
Roberto Rojas
LALuis F. Aguilar
Luis F. Aguilar
PCPatricio Armando Carvajal-Rondanelli
Patricio Armando Carvajal-Rondanelli
Fernando AlbericioFernando Albericio
Fernando Albericio
Constanza Cárdenas CarvajalConstanza Cárdenas Carvajal
Constanza Cárdenas Carvajal
Cell-penetrating peptides rich in arginine are good candidates to be considered as antibacterial compounds, since peptides have a lower chance of generating resistance than commonly used antibiotics. Model homopeptides are a useful tool in the study of activity and its correlation with a secondary structure, constituting an initial step in the construction of functional heteropeptides. In this report, the 11-residue arginine homopeptide (R11) was used to determine its antimicrobial activity against Staphylococcus aureus and Escherichia coli and the effect on the secondary structure, caused by the substitution of the arginine residue by the amino acids Ala, Pro, Leu and Trp, using the scanning technique. As a result, most of the substitutions improved the antibacterial activity, and nine peptides were significantly more active than R11 against the two tested bacteria. The cell-penetrating characteristic of the peptides was verified by SYTOX green assay, with no disruption to the bacterial membranes. Regarding the secondary structure in four different media—PBS, TFE, E. coli membrane extracts and DMPG vesicles—the polyproline II structure, the one of the parent R11, was not altered by unique substitutions, although the secondary structure of the peptides was best defined in E. coli membrane extract. This work aimed to shed light on the behavior of the interaction model of penetrating peptides and bacterial membranes to enhance the development of functional heteropeptides.

Verified
Journal Article
Open access
PDF file
MMMaria Salvador Mira
Maria Salvador Mira
VCVeronica Chico
Veronica Chico
MAMónica Aróstica
Mónica Aróstica
FGFanny Guzmán
Fanny Guzmán
NRNerea Roher
Nerea Roher
MOMaria del Mar Ortega-Villaizan
Maria del Mar Ortega-Villaizan
One of the challenges of science in disease prevention is optimizing drug and vaccine delivery. Until now, many strategies have been employed in this sector, but most are quite complex and labile. To overcome these limitations, great efforts are directed to coupling drugs to carriers, either of natural or synthetic origin. Among the most studied cell carriers are antigen-presenting cells (APCs), however, red blood cells (RBCs) are positioned as attractive carriers in drug delivery due to their abundance and availability in the body. Furthermore, fish RBCs have a nucleus and have been shown to have a strong involvement in modulating the immune response. In this study, we evaluated the binding of three peptides to rainbow trout RBCs, two lectin-like peptides and another derived from Plasmodium falciparum membrane protein, in order to take advantage of this peptide-RBCs binding to generate tools to improve the specificity, efficacy, immunostimulatory effect, and safety of the antiviral therapeutic or prophylactic administration systems currently used.